Canadian national consensus guidelines for naloxone prescribing by pharmacists
Can Pharm J (Ott)
.
2020 Aug 26;153(6):347-351.
doi: 10.1177/1715163520949973.
eCollection 2020 Nov-Dec.
Authors
Ross T Tsuyuki
1
2
3
4
5
6
7
8
9
,
Vinita Arora
1
2
3
4
5
6
7
8
9
,
Mark Barnes
1
2
3
4
5
6
7
8
9
,
Michael A Beazely
1
2
3
4
5
6
7
8
9
,
Michael Boivin
1
2
3
4
5
6
7
8
9
,
Anna Christofides
1
2
3
4
5
6
7
8
9
,
Harsit Patel
1
2
3
4
5
6
7
8
9
,
Julie Laroche
1
2
3
4
5
6
7
8
9
,
Aaron Sihota
1
2
3
4
5
6
7
8
9
,
Randy So
1
2
3
4
5
6
7
8
9
Affiliations
1
University of Alberta (Tsuyuki, So), Edmonton, Alberta.
2
University of Toronto (Arora), Toronto.
3
RespectRx (Barnes), Ottawa.
4
University of Waterloo (Beazely), Waterloo.
5
CommPharm Consulting (Boivin), Barrie.
6
IMPACT Medicom Inc. (Christofides), Toronto.
7
Hamilton General Hospital (Patel), Hamilton Health Sciences, Hamilton, Ontario.
8
Familiprix (Laroche), St-Lin-Laurentides, Quebec.
9
University of British Columbia (Sihota), Vancouver, BC.
PMID:
33282024
PMCID:
PMC7689616
DOI:
10.1177/1715163520949973
No abstract available